The next question that must be answered is whether this is another material breakthrough that is more scientific marketing than substance? Is this really a game changer? Will the market see a company that will expand the use of SiN into coated ceramic pedicle screws? Based on Amedica's press release, the company makes it sound as though they are a bigger player in the spine market than they really are. If this acquisition positions them as a well balanced company, what were they really buying. Another pedicle screw? The opportunity to eliminate their licensing distribution agreement with Integra/Theken Spine for the Tether plate? The facet gun? Could that market be smaller than all the looney toon analysts' predict? Where is the leading edge technology for spine in this acquisition? Even if Amedica can develop a disc out of SiN, what effect will that have on an already cluttered artificial disc market. Will they tout that their disc will be the 5th or 6th generation disc?
In all likelihood, this acquisition was made to position themselves for an IPO, whenever this dogged economy gets back on its feet. This company has talked about IPO since last summer. Based on this acquisition, there isn't enough firepower in the current portfolio to position this for a sale to a legacy company. If anything, the potential of utilizing SiN in total joint implants is where the goose with the golden egg really lies. In closing, if Amedica really wants some credibility, why don't they disclose all the surgeons that are consultants and/or investors in this company? TSB believes that SiN can be a game breaker in recon, but spine? In addition, how much more will they drive up the cost of interbody devices, when there is an all out war in the marketplace surrounding the ASP of this product segment? TSB wants to know what you think.